Abstract:Purpose: Thalassemia is a severe hereditary blood disorder that poses a significant threat to human health and leads to mortality and disability. It is one of the most prevalent monogenic diseases worldwide. The aim of this study was to analyze the molecular epidemiological data of individuals of childbearing age from the Han ethnic group with thalassemia in Southwest China and to explore the application of next-generation sequencing (NGS) technology in screening thalassemia carriers. Methods: The participants were Han males and females of childbearing age who sought medical advice at the West China Second University Hospital, Sichuan University from June 2022 to June 2023. We detected α- and β-thalassemia mutations using full-length capture of the thalassemia genes and NGS technology. Results: In a cohort of 1,093 participants, 130 thalassemia carriers were identified, with an overall detection rate of 11.89% (130/1,093). Among these, 0.91% (10/1,093) had mutations that could not be detected using traditional PCR techniques. The proportions of carriers with α-, β-, and α-complexed β-thalassemia gene mutations were 7.68% (84/1,093), 3.93% (43/1,093), and 0.27% (3/1,093), respectively. We identified a novel HBA2 c.166del variant that has not been previously reported. Conclusion: Using NGS technology, we found that the mutation-carrying rate of thalassemia genes was 11.89% in the Han population of childbearing age in Southwest China. Compared with the results of traditional PCR techniques, NGS detected an additional 0.91% (10/1,093) rare genetic variants. NGS technology should be utilized as the primary screening method for thalassemia carriers among Han nationality people of childbearing age in Southwest China.

Report of Two Novel Thalassemia Variants, HBB: c.181delG and HBA1: c.121_126delAAGACC, in Chinese Individuals

Identification of Two Novel β-Thalassemia Mutations (HBB: c.335-346del and HBB: c.108 C > G) in Han Chinese

Characterization of a novel HBB:c.194dup variant of the β-globin gene combined with six alpha genes

Two Novel Β-Thalassemia Gene Mutations Were Detected in Chinese Patients: CD13/14(-C) and Beta Nt1582(a>g), PolyA(AATAAA>GATAAA)

A Novel Mutation at HBA1: c.349G>T Causing α-Thalassemia in a Chinese Family

Third‐generation sequencing identified two rare α‐chain variants leading to hemoglobin variants in Chinese population

Two Novel Deletion Mutations in Β-Globin Gene Cause Β-Thalassemia Trait in Two Chinese Families

AB034. Hemoglobinopathies in China and SEA: Rapid Targeted Deep Sequencing for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies

Characterization of a novel 8.2 kb deletion causing beta-thalassemia

Case report: A novel 10.8-kb deletion identified in the β-globin gene through the long-read sequencing technology in a Chinese family with abnormal hemoglobin testing results

Five novel globin gene mutations identified in five Chinese families by next-generation sequencing

Third-generation sequencing identified a novel complex variant in a patient with rare alpha-thalassemia

Identification of a Novel 7-Bp Deletion in the Α-Globin Gene Cluster in One Chinese Family.

A Novel Frameshift Mutation(HBA2:C.337delC) Associated With α-Thalassemia Trait Detected by Next-Generation Sequencing in Southern China

[Analysis of five Chinese individuals with rare thalassemia mutation HBB: c.93-21G＞A]

A novel 15.8 kb deletion α-thalassemia confirmed by long-read single-molecule real-time sequencing: Hematological phenotypes and molecular characterization

Novel Promoter Mutation (HBB:C.-139_-138del) Associated with β-Thalassemia Trait Detected by Next-Generation Sequencing in Southern China

Hb H disease associated with compound heterozygosity for --SEA deletion and a novel alpha globin chain variant (HBA2:c.175C>A) on the distal histidine in a Chinese family

Identification of a novel 10.3 kb deletion causing α 0 -thalassemia by the third-generation sequencing: pedigree analysis and genetic diagnosis

Identification of a Novel Β-Thalassemia Mutation at Codon 130 (+T) (HBB: C.391inst) in Han Chinese.

Screening for thalassemia carriers among the Han population of childbearing age in Southwestern of China